Medicine News and Research

RSS

Report finds geographic variation in the use of carotid endarterectomy, carotid stenting

Medicare beneficiaries in some parts of the United States appear more likely to receive carotid endarterectomy, a surgical procedure to clear blockages in the artery supplying blood to the head, whereas those in other regions more often receive stents for the same condition, according to a report in the July 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

27 Jul 2010

NCCN enters into collaboration to introduce Proventys CDS Oncology system

The National Comprehensive Cancer Network and Proventys, a leader in advanced decision support technologies, have entered into an exclusive collaboration to introduce the Proventys CDS Oncology system, a first-of-its-kind Web platform that arms oncologists with expert recommendations and evidence facilitating the delivery of high-quality, individualized patient care.

27 Jul 2010

Albert Einstein College of Medicine receives research grant to help people with MDR-TB

For the third time in four months, the National Institute of Allergy and Infectious Diseases of the National Institutes of Health has awarded Albert Einstein College of Medicine of Yeshiva University a research grant aimed at helping people infected with multidrug-resistant tuberculosis. Taken together, all three NIH grants total $8.57 million.

27 Jul 2010

Cedars-Sinai Medical Center receives third consecutive full accreditation from AAHRPP

Cedars-Sinai Medical Center has received its third consecutive full accreditation from the Association for the Accreditation of Human Research Protection Programs, Inc., whose goal is to ensure that research institutions meet the highest standards in respecting and protecting individuals who participate in research.

27 Jul 2010

Iverson Genetic Diagnostics receives CMS approval for Warfarin clinical study

Iverson Genetic Diagnostics today announced the company has received approval from CMS to conduct a WARFARIN Clinical Study. The two-year (2) study will assess the impact of genetic information in calculating doses and the changes in the rate of adverse events when initiating Warfarin drug therapy. These changes will be compared against doses initiated without genetic data. The randomized and blinded, multi-center study will involve more than 7000 participants at over 50 sites nationwide.

27 Jul 2010

Primary care shortages affect even doctor-heavy Massachusetts

The Boston Globe: Despite being home to the largest number of doctors per person, finding a primary care physician has been getting more difficult for Massachusetts residents since 2006, according a report released by the state. "Last year 60 percent of family-medicine doctors' offices were accepting new patients, down from 70 percent in 2007, the first full year after the state mandated near-universal health insurance coverage. Last year only 44 percent of internal medicine practices were accepting new patients, down from 66 percent in 2005.

27 Jul 2010

Braun Corporation presents key themes, recommendations discussed at symposium for the disabled

The Braun Corporation, the world's largest manufacturer of wheelchair-accessible vans, ramps and wheelchair lifts, today published key insights from a symposium hosted recently in Washington, D.C. titled "ADA 20/20: Looking Back, Looking Forward on Mobility." In anticipation of the 20th anniversary of the Americans with Disabilities Act, the panel of key thought leaders from government, medicine, academia and business exchanged insights on current thinking around future mobility needs for Americans with disabilities.

27 Jul 2010

Study on treatment needs of prostate cancer patients with low level PSA

Controversy has long existed over the benefit of the prostate specific antigen (PSA) test used to screen for the presence of prostate cancer, and there has been little study to document the risk profile of men who have a PSA level at or below what is considered 'normal.' New research published in the latest edition of Archives of Internal Medicine (Vol. 170, No. 14) by a team of investigators at The Cancer Institute of New Jersey (CINJ), further explores this population. The findings show that most men with prostate cancer who tested below the normal PSA level and had low-risk disease nevertheless underwent aggressive treatment. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.

27 Jul 2010

Childhood cancer survival associated with high risk of abnormal cardiac function

Childhood cancer survival is associated with increased risk of long-term abnormalities in cardiac function, according to a report in the July 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

27 Jul 2010

Medical device complications send more than 70,000 kids to ER annually

The Associated Press: The first detailed national estimate on complications in medical device use by children says that more than 70,000 kids a year have to go to emergency rooms because of complications from medical devices, with contact lenses the leading culprit. "About one-fourth of the problems were things like infections and eye abrasions in contact lens wearers.

27 Jul 2010

Novartis launches new OTC children's liquid acetaminophen product

Novartis announces the introduction of Triaminic™ Fever Reducer Pain Reliever, the only branded over-the-counter children's liquid acetaminophen product currently available nationwide in the US. Triaminic® now offers parents a product that combines the pain relieving and fever-reducing power of acetaminophen with the brand that has been trusted by pediatricians and parents for more than 50 years.

27 Jul 2010

AHF denies BMS sales reprepresentatives access to healthcare centers

Today AIDS Healthcare Foundation (AHF) announced that it has banned pharmaceutical sales representatives from Bristol-Myers Squibb (BMS) from calling on AHF's medical providers and staff in its sixteen U.S. healthcare centers. The decision is based on BMS' refusal to lower the price of its key AIDS drug Reyataz for cash-strapped AIDS Drug Assistance Programs.

27 Jul 2010

Johns Hopkins scientist wins $2.5M NIH Director's Pioneer Award

A Johns Hopkins scientist who proposes to design and create an all-new series of novel drugs is one of 17 winners of a special grant known as a Director's Pioneer Award from the National Institutes of Health.

27 Jul 2010

Scientists find MODS technique most accurate for testing tuberculosis in children

An international team of researchers comparing recently-developed methods for diagnosing tuberculosis in children in resource-poor countries has concluded that the best test for high-risk children is the microscopic-observation drug-susceptibility (MODS) technique using two gastric aspirate specimens from each child tested. MODS detects the presence of bacteria causing tuberculosis using microscopes to detect typical growth patterns in culture broth.

27 Jul 2010

UCLA Health System launches hand transplantation program

The UCLA Health System has launched the new UCLA Hand Transplantation Program, the first of its kind on the West Coast and only the fourth such center in the United States. The program will help those who have suffered the traumatic loss of a hand or forearm and allow them to regain function and improve their quality of life. Qualified candidates are now being sought for a clinical study of the procedure.

27 Jul 2010

Scientists discover mechanism of herpes virus cell entry machinery

The mechanism by which a herpes virus invades cells has remained a mystery to scientists, but now research from Tufts University and the University of Pennsylvania reveals the unusual structure of a key member of the protein complex that allows a herpes virus to invade cells.The new map details an essential piece of the herpes virus "cell-entry machinery," providing scientists with a new target for antiviral drugs.

27 Jul 2010

New drug for type 2 diabetes, Effect of insulin on bones

In a groundbreaking finding, a new medicine Galvus (vildagliptin) has been created for people with type 2 diabetes that would lower blood glucose levels without the side effects of other medications.

26 Jul 2010

Adventist Hinsdale Hospital, Marianjoy announce partnership

Patients with acute physical rehabilitation needs now can undergo inpatient treatment close to home thanks to a new partnership between Adventist Hinsdale Hospital and Marianjoy Rehabilitation Hospital. Announced today, the cooperative effort unites two organizations with similar holistic approaches to rehabilitative patient care for a variety of conditions in multiple settings.

26 Jul 2010

East Tennessee Children's Hospital selects ProVation Order Sets, powered by UpToDate Decision Support

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that East Tennessee Children's Hospital has selected ProVation® Order Sets, powered by UpToDate® Decision Support, to automate the creation, deployment and maintenance of order sets.

26 Jul 2010

CPC partners with CU School of Medicine on stem cell research

A major research company with expertise in managing clinical trials is partnering with the University of Colorado's Anschutz Medical Campus to more efficiently bring the latest stem cell discoveries from the laboratory to the patient.

26 Jul 2010